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Abstract
Data on validity of self-reported vaccinations are scarce. This
study, performed on healthcare students in Paris (France), aimed
to evaluate this validity for occupational vaccinations. The validity
of self-reported vaccination status was compared with written
information. A total of 432 students were enrolled. Sensitivity
rates for BCG, hepatitis B and measles were over 74%. For
diphtheria-tetanus-polio and pertussis, sensitivity was below 50%.
Specificity was between 70 and 95% for dTP-pertussis, and below
35% for all others. Overall, the validity of self-reported informa-
tion was low, meaning that checking medical records remains the
preferable strategy for assessing immunization status.
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Healthcare workers and students (HCS) must be vaccinated to
protect themselves and susceptible patients from
healthcare-acquired infections [1]. In France, occupational
vaccinations are either mandatory or recommended [2]. High
vaccine coverage is all the more important because nosocomial
outbreaks have been described in Europe [3].
Use of self-reported vaccination status is commonplace for
assessing vaccination coverage, yet limited validity data exist.
The validity of self-reported vaccination is good in the general
population for pneumococcal and influenza vaccines [4–8].
Three studies have assessed the validity of self-reported
vaccination status in HCS [9–11]. They targeted only measles
[9–11] and hepatitis B [10] vaccines; they were single-centre
studies and none had adjusted estimates for potential
confounders. All these studies have used serology to assess
the immunization status, and none has evaluated the validity of
self-reported vaccination status among HCS as compared with
medical immunization records. It would be logical to assume
that HCS would be more aware of occupational immunization
than the general population, and therefore would give more
reliable data regarding their vaccination status.
We conducted a survey in 2009, which aimed to assess the
vaccination coverage of HCS in Paris teaching hospitals. The
methodology and results of vaccination coverage have been
published elsewhere [12]. The objective of the present study
was to evaluate the validity of vaccination status reported by
HCS for occupational vaccinations, compared with immuniza-
tion records. Detailed methods of this analysis are presented
as Data S1.
Among the 488 eligible students, 432 (89%) were finally
included: 178 doctors, 147 nurses and 107 midwives. A health
booklet was available for 381 (86%) students (Table 1).
Students with a health booklet were not different from
students without one, regarding age (p 0.93), gender (p 0.11),
year of study (p 0.62) and type of healthcare school (p 0.22).
Confirmed vaccination coverage data for all occupational
vaccinations are presented as Data S1.
Table 2 compares the students’ self-reported vaccination
status with the health booklet data. Rates of sensitivity can be
divided into three groups: high sensitivity (>90%) for BCG and
the first dose of hepatitis B vaccine; mild sensitivity (between
70 and 90%) for the first and second doses of measles vaccine
and the second and third doses of hepatitis B vaccine; and low
sensitivity (below 70%) for DTP and pertussis. Specificity was
between 70 and 95% for DTP-pertussis, and below 35% for all
the other vaccines. Positive predictive value (PPV) was high
(>90%) for the three doses of hepatitis B and BCG, mild for
the first dose of measles and DTP, and low for the other
vaccines. Negative predictive value was mild for pertussis and
low for all the other vaccines. Estimates adjusted for the
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factors of interest (gender, age, year of study and type of
teaching institution) showed little variations from the unad-
justed estimates (Data S1).
Our study showed that overall, the validity of self-reported
vaccination status for occupational vaccines among HCS was
quite poor. These findings suggest that it is necessary to check
the vaccination booklets, because self-reported data for the
five studied occupational vaccines cannot be trusted. This
might be the consequence of a lack of interest in vaccination, a
lack of knowledge and/or memory issues. The complexity of
the vaccination schedule in children and adolescents may also
contribute to the problem.
Two vaccines (BCG and first dose of hepatitis B) showed a
high sensitivity and high PPV for their self-reported vaccination
status, but the specificity was very low. The high PPV is the
consequence of the high coverage rate of these two vaccines. In
contrast, the other occupational vaccines (DTP, pertussis and
measles) showed low sensitivity, with high specificity only for
pertussis and DTP. Interestingly, vaccines with regular boosters,
such as DTP and DTP-pertussis, showed better levels of
specificity than the other vaccines, possibly because it is easier
to remember not receiving a dose at regular intervals. Con-
versely, for vaccines without boosters, such as BCG, hepatitis B
and measles, the sensitivity rates were higher than for the other
vaccines. Of note, age, gender, year of study and type of teaching
institution did not impact significantly on validity estimates.
The analysis of the published articles based on serol-
ogy-confirmed immune status showed poor sensitivity and
specificity of self-reported data for measles vaccine [9–11]. In
our study, we also found mild sensitivity and poor specificity of
TABLE 1. Characteristics of the healthcare students included in the study (N = 432, weighted statistics)
Medical students Midwifery students Nursing students
Total(N = 178) (N = 107) (N = 147)
Mean age (min–max) 23.1 (20–45) 22.2(20–36) 24.3(19–44) 23.4 (19–45)
Sex ratio (M/F) 0.68 0.05 0.14 0.46
Distribution by year of studya (%)
First year 9.9 22.8 27.9
Second year 35.7 29.8 32.6
Third year 38.9 23.9 39.5
Fourth year 15.5 23.6
With a vaccination booklet (%) 84.2 86.4 90.2 85.9
aThe training period considered in this study lasts up to 4 years: from the third to the sixth year of study in medical schools, corresponding to the first contacts of students with
patients; the 4 years of the midwifery curriculum; and the 3 years of the nursing curriculum.
TABLE 2. Validity of the students’ self-reported DTP, pertussis, hepatitis B, BCG and measles vaccination status, compared with
immunization records (unadjusted weighted estimates) (N = 381)
Self-reported data
Sensitivity (%) Specificity (%) PPV (%) NPV (%)
Vaccinated Unvaccinated [95% CI] [95% CI] [95% CI] [95% CI]
DTP 11–13
Vaccinated 97 158 33.8 [24.9–44.1] 73.0 [59.9–83.0] 69.8 [57.3–79.9] 37.5 [27.9–48.1]
Unvaccinated 32 94
DTP 16–18
Vaccinated 114 168 45.8 [37.3–54.5] 71.0 [55.9–82.5] 85.1 [74.7–91.7] 26.6 [20.6–33.6]
Unvaccinated 27 72
DTP-pertussis 11–13
Vaccinated 14 90 11.8 [5.6–23.0] 85.5 [77.3–91.0] 20.1 [8.3–41.2] 75.7 [68.4–81.8]
Unvaccinated 48 229
DTP-pertussis 16–18
Vaccinated 21 82 18.1 [8.8–33.6] 95.4 [91.9–97.5] 54.1 [32.4–74.4] 79.7 [73.3–84.9]
Unvaccinated 19 259
Hepatitis B – first dose
Vaccinated 361 7 98.4 [95.8–99.4] 2.6 [0.3–17.8] 95.5 [90.4–97.9] 7.2 [0.9–40.2]
Unvaccinated 12 1
Hepatitis B – second dose
Vaccinated 319 46 87.9 [80.4–92.8] 9.3 [1.8–37.0] 94.6 [89.3–97.4] 4.1 [0.8–17.8]
Unvaccinated 14 2
Hepatitis B – third dose
Vaccinated 260 94 74.2 [65.5–81.4] 27.7 [12.1–51.7] 91.8 [85.9–95.3] 9.0 [3.7–20.3]
Unvaccinated 18 9
Tuberculosis
Vaccinated 349 6 97.6 [94.0–99.1] 5.5 [1.2–22.7] 93.5 [88.9–96.2] 14.4 [2.6–51.9]
Unvaccinated 24 2
Measles – first dose
Vaccinated 260 39 87.0 [79.4–92.1] 32.6 [19.7–48.8] 81.2 [73.2–87.2] 42.9 [27.7–59.5]
Unvaccinated 58 24
Measles – second dose
Vaccinated 154 42 79.5 [71.2–86.0] 30.2 [20.7–41.9] 48.4 [38.8–58.2] 64.2 [50.8–75.7]
Unvaccinated 133 52
DTP, diphtheria-tetanus-polio; PPV, positive predictive value; NPV, negative predictive value.
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self-reported data, and we noticed an important difference
between the PPV of the first and the second measles dose
(81.2% vs. 48.4%). In comparison, Wicker et al. [11] found no
difference in their study. The gap we observed could be due to
the fact that the French recommendation for the second dose
came 10 years after the recommendation for the first dose.
Our work reports original results that could have an impact
on practice. This multicentre survey assessed the validity of
self-reported vaccination status for five out of seven occupa-
tional vaccines in a large representative sample of HCS.
Moreover, the few published single-centre studies that have
assessed the validity of self-reported vaccination status com-
pared with serology, targeted only a few vaccines in a selected
population of HCS, without adjusting estimates for potential
confounders. Our work has, however, some limitations. Firstly,
our results came only from one large French region, but from 15
different teaching hospitals. Even if we cannot claim that our
results are representative of the whole country, the fact that in
France recommendations for immunization are national and
supposed to be followed everywhere makes us think that our
findings are not likely to be biased. Secondly, we cannot rule out
the possibility that vaccination booklets were not always
completed for individuals who were truly vaccinated. If there
were any false-negative records, the true sensitivity and PPV
would be higher than what was found in our analysis.
In conclusion, the validity of self-reported information
regarding vaccination status was poor among HCS. Checking
vaccination history by immunization record review remains
the preferable strategy. Immunization registries would be the
ideal source for such data [13]. The development of individual
electronic vaccination booklets could also help to better
ascertain vaccination status.
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